Pharmacology for Nurses Unit 30 Review: Gastrointestinal Disorder Drugs

What's This Unit All About?

• Focuses on pharmacological treatments for various gastrointestinal (GI) disorders
• Covers the major drug classes used to manage and treat GI issues
• Explores the mechanisms of action, indications, and contraindications for each drug class
• Discusses potential side effects and important nursing considerations when administering these medications
• Provides real-life examples and case studies to illustrate the application of GI disorder drugs in clinical practice
• Emphasizes the role of nurses in monitoring patients receiving these medications and educating them about proper use and potential adverse effects
• Highlights the importance of understanding the pharmacodynamics and pharmacokinetics of GI disorder drugs to ensure safe and effective patient care

Key Terms You Need to Know

• Proton pump inhibitors (PPIs): medications that reduce stomach acid production by blocking the enzyme responsible for acid secretion
• H2 receptor antagonists (H2RAs): drugs that decrease stomach acid production by blocking histamine receptors in the stomach
• Antacids: medications that neutralize stomach acid and provide quick relief from heartburn and indigestion
• Prokinetics: drugs that stimulate GI motility and help alleviate symptoms of gastroparesis and other motility disorders
• Laxatives: medications used to treat constipation by promoting bowel movements through various mechanisms (osmotic, stimulant, or bulk-forming)
• Antidiarrheals: drugs that help control and reduce diarrhea by slowing down intestinal motility or altering fluid and electrolyte balance
• Antiemetics: medications used to prevent or treat nausea and vomiting by targeting various receptors in the brain and GI tract
• Inflammatory bowel disease (IBD): a group of chronic disorders (Crohn's disease and ulcerative colitis) characterized by inflammation of the GI tract

Common GI Disorders We'll Cover

• Gastroesophageal reflux disease (GERD): a chronic condition in which stomach acid flows back into the esophagus, causing heartburn and other symptoms
• Peptic ulcer disease (PUD): the development of open sores in the lining of the stomach or duodenum, often caused by H. pylori infection or NSAID use
• Gastroparesis: a condition characterized by delayed stomach emptying, leading to symptoms such as nausea, vomiting, and early satiety
• Irritable bowel syndrome (IBS): a functional GI disorder that causes abdominal pain, bloating, and changes in bowel habits (diarrhea or constipation)
• Inflammatory bowel disease (IBD): chronic inflammation of the GI tract, including Crohn's disease and ulcerative colitis
• Constipation: infrequent or difficult bowel movements, often accompanied by straining and abdominal discomfort
• Diarrhea: frequent, loose, or watery stools that can lead to dehydration and electrolyte imbalances
• Nausea and vomiting: common symptoms associated with various GI disorders, as well as side effects of certain medications or treatments

Major Drug Classes for GI Issues

• Proton pump inhibitors (PPIs): used to treat GERD, PUD, and other acid-related disorders by reducing stomach acid production (omeprazole, lansoprazole)
• H2 receptor antagonists (H2RAs): prescribed for GERD and PUD to decrease stomach acid secretion (ranitidine, famotidine)
• Antacids: provide quick relief from heartburn and indigestion by neutralizing stomach acid (calcium carbonate, magnesium hydroxide)
• Prokinetics: stimulate GI motility and help manage gastroparesis and other motility disorders (metoclopramide, domperidone)
• Laxatives: used to treat constipation by promoting bowel movements through various mechanisms (polyethylene glycol, senna, bisacodyl)
• Antidiarrheals: help control and reduce diarrhea by slowing intestinal motility or altering fluid balance (loperamide, bismuth subsalicylate)
• Antiemetics: prevent or treat nausea and vomiting by targeting receptors in the brain and GI tract (ondansetron, promethazine)
• Aminosalicylates: anti-inflammatory drugs used to treat IBD by reducing inflammation in the GI tract (mesalamine, sulfasalazine)

How These Drugs Work

• PPIs irreversibly block the H+/K+ ATPase enzyme in the stomach, reducing acid secretion
  • This enzyme is responsible for the final step in the production of hydrochloric acid
  • By inhibiting this enzyme, PPIs effectively decrease the amount of acid produced by the stomach
• H2RAs competitively bind to histamine receptors in the stomach, preventing histamine from stimulating acid secretion
  • Histamine is a key stimulator of acid production in the stomach
  • By blocking histamine receptors, H2RAs reduce the amount of acid secreted by the stomach
• Antacids contain alkaline substances that react with and neutralize stomach acid
  • They provide rapid relief from heartburn and indigestion by raising the pH of the stomach contents
  • Antacids do not reduce acid production but instead counteract the effects of existing acid
• Prokinetics stimulate GI motility by acting on various receptors and neurotransmitters
  • Metoclopramide is a dopamine receptor antagonist that increases the contractions of the stomach and small intestine
  • Domperidone is a peripheral dopamine receptor antagonist that enhances GI motility without crossing the blood-brain barrier
• Laxatives promote bowel movements through different mechanisms
  • Osmotic laxatives (polyethylene glycol) draw water into the intestines, softening stool and increasing bowel movements
  • Stimulant laxatives (senna, bisacodyl) stimulate intestinal contractions and accelerate transit time
  • Bulk-forming laxatives (psyllium) absorb water and increase stool volume, promoting regular bowel movements
• Antidiarrheals work by slowing intestinal motility or altering fluid and electrolyte balance
  • Loperamide is an opioid receptor agonist that reduces intestinal contractions and prolongs transit time
  • Bismuth subsalicylate has antisecretory and anti-inflammatory properties that help reduce diarrhea
• Antiemetics target various receptors involved in the pathophysiology of nausea and vomiting
  • Ondansetron is a selective 5-HT3 receptor antagonist that blocks serotonin-induced nausea and vomiting
  • Promethazine is an H1 receptor antagonist with antiemetic properties, acting on the chemoreceptor trigger zone
• Aminosalicylates exert anti-inflammatory effects in the GI tract
  • They inhibit the production of pro-inflammatory mediators such as prostaglandins and leukotrienes
  • Aminosalicylates also act as antioxidants and free radical scavengers, reducing oxidative stress in the gut

Side Effects and What to Watch For

• PPIs: headache, diarrhea, abdominal pain, increased risk of osteoporosis and infections (pneumonia, C. difficile)
• H2RAs: headache, dizziness, constipation, diarrhea, confusion (especially in elderly patients)
• Antacids: constipation, diarrhea, electrolyte imbalances (with excessive use), drug interactions (altered absorption of other medications)
• Prokinetics: drowsiness, fatigue, diarrhea, extrapyramidal symptoms (metoclopramide), QT prolongation (domperidone)
• Laxatives: abdominal cramps, bloating, electrolyte imbalances (with excessive use), dependence (stimulant laxatives)
• Antidiarrheals: constipation, abdominal pain, dizziness, drowsiness, toxic megacolon (rare, in patients with IBD)
• Antiemetics: drowsiness, dry mouth, constipation, extrapyramidal symptoms (promethazine), headache, QT prolongation (ondansetron)
• Aminosalicylates: headache, nausea, diarrhea, allergic reactions, nephrotoxicity (rare), blood dyscrasias (rare)

Nursing Considerations

• Assess patient's GI symptoms, medical history, and medication regimen before administering GI disorder drugs
• Monitor patients for therapeutic response and potential adverse effects
  • Regularly assess symptom relief, bowel habits, and overall GI function
  • Be vigilant for signs of side effects or complications, such as electrolyte imbalances or infections
• Educate patients about proper medication use, including dosage, timing, and potential side effects
  • Emphasize the importance of adherence to the prescribed regimen
  • Provide written instructions and encourage patients to ask questions
• Administer medications as directed and adjust dosages based on patient response and healthcare provider orders
• Monitor for drug interactions, especially when patients are taking multiple medications
  • Be aware of potential interactions between GI disorder drugs and other medications, such as antibiotics or antidepressants
  • Consult with a pharmacist or refer to drug interaction databases when necessary
• Promote lifestyle modifications that can help manage GI disorders
  • Encourage patients to maintain a healthy diet, stay hydrated, and engage in regular physical activity
  • Discuss stress management techniques and the importance of getting adequate sleep
• Collaborate with healthcare providers to develop and implement comprehensive treatment plans
  • Communicate patient progress, concerns, and any changes in condition to the healthcare team
  • Participate in interdisciplinary rounds and care conferences to ensure continuity of care

Real-Life Application

• Case Study 1: A 45-year-old patient with a history of GERD presents with worsening heartburn and regurgitation. The healthcare provider prescribes a PPI (omeprazole) to be taken daily. The nurse educates the patient about the medication, emphasizing the importance of taking it 30 minutes before a meal for optimal effectiveness. The nurse also advises the patient to avoid triggers such as spicy foods, caffeine, and alcohol. At a follow-up visit, the patient reports significant improvement in symptoms and better quality of life.

• Case Study 2: A 70-year-old patient with chronic constipation has been prescribed a stimulant laxative (bisacodyl) to promote regular bowel movements. The nurse instructs the patient to take the medication as directed and to drink plenty of water throughout the day. The nurse also emphasizes the importance of a high-fiber diet and regular exercise to help alleviate constipation. The patient is advised to contact the healthcare provider if constipation persists or if abdominal pain or bloating occurs.

• Case Study 3: A 30-year-old patient with Crohn's disease is experiencing a flare-up of symptoms, including abdominal pain, diarrhea, and rectal bleeding. The healthcare provider prescribes an aminosalicylate (mesalamine) to reduce inflammation in the GI tract. The nurse educates the patient about the medication, including potential side effects such as headache and nausea. The nurse also stresses the importance of taking the medication as prescribed, even when symptoms improve, to maintain remission. The patient is encouraged to attend regular follow-up appointments to monitor disease activity and adjust treatment as needed.